Taken together, our data demonstrate that in a nurturing environment, iPSCs derived from people with stable and progressive MS are capable of differentiating into mature OLs, but that this process is profoundly inhibited by chronic exposure to low-dose IFNγ. This evidence concerns the gene IFNG and myeloid sarcoma.